AEROSOLIZED TARGETED NANOERYTHROSOMES CONTAINING FASUDIL, A RHO-KINASE INHIBITOR, FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

被引：0
|
作者：
Gupta, N. [1 ]
Patel, B. [1 ]
Ahsan, F. [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Amarillo, TX 79106 USA
来源：
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2014年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
34
引用
收藏
页码：A13 / A13
页数：1
相关论文
共 50 条
  • [1] Effects of the Rho-Kinase Inhibitor, Fasudil, on Pulmonary Hypertension
    Odagiri, Keiichi
    Watanabe, Hiroshi
    CIRCULATION JOURNAL, 2015, 79 (06) : 1213 - 1214
  • [2] Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
    Gupta, Vivek
    Gupta, Nilesh
    Shaik, Imam H.
    Mehvar, Reza
    McMurtry, Ivan F.
    Oka, Masahiko
    Nozik-Grayck, Eva
    Komatsu, Masanobu
    Ahsan, Fakhrul
    JOURNAL OF CONTROLLED RELEASE, 2013, 167 (02) : 189 - 199
  • [3] Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension
    Hiroshi Fujita
    Yoshihiro Fukumoto
    Kenya Saji
    Koichiro Sugimura
    Jun Demachi
    Jun Nawata
    Hiroaki Shimokawa
    Heart and Vessels, 2010, 25 : 144 - 149
  • [4] Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension
    Fujita, Hiroshi
    Fukumoto, Yoshihiro
    Saji, Kenya
    Sugimura, Koichiro
    Demachi, Jun
    Nawata, Jun
    Shimokawa, Hiroaki
    HEART AND VESSELS, 2010, 25 (02) : 144 - 149
  • [5] Acute Effects of Rho-Kinase Inhibitor Fasudil on Pulmonary Arterial Hypertension in Patients With Congenital Heart Defects
    Xiao, Jia-wang
    Zhu, Xian-yang
    Wang, Qi-guang
    Zhang, Duan-zhen
    Cui, Chun-sheng
    Zhang, Po
    Chen, Huo-yuan
    Meng, Li-li
    CIRCULATION JOURNAL, 2015, 79 (06) : 1342 - 1348
  • [6] Rho-kinase inhibitor, fasudil, reduces pulmonary vascular resistance in patients with severe pulmonary hypertension
    Fukumoto, Y
    Matoba, T
    Abe, K
    Ito, A
    Shimokawa, H
    CIRCULATION, 2003, 108 (17) : 525 - 525
  • [7] Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension
    Fukumoto, Y
    Matoba, T
    Ito, A
    Tanaka, H
    Kishi, T
    Hayashidani, S
    Abe, K
    Takeshita, A
    Shimokawa, H
    HEART, 2005, 91 (03) : 391 - 392
  • [8] Rho-Kinase Inhibitors Targeted To The Pulmonary Vasculature For Treatment Of Pulmonary Hypertension
    Morena, D. T.
    Hanson, S.
    Terry, M.
    Blood, A.
    Wilson, S.
    Giri, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] Intravenous administration of a Rho-kinase inhibitor, fasudil, reduces pulmonary vascular resistance in patients with pulmonary hypertension
    Fukumoto, Y
    Hirakawa, Y
    Abe, K
    Koike, G
    Mohri, M
    Shimokawa, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 170 - 171
  • [10] Attenuation of Pulmonary Hypertension Secondary to Left Ventricular Dysfunction in the Rat by Rho-Kinase Inhibitor Fasudil
    Dai, Zen-Kong
    Wu, Bin-Nan
    Chen, I-Chen
    Chai, Chee-Yin
    Wu, Jiunn-Ren
    Chou, Shah-Hwa
    Yeh, Jwu-Lai
    Chen, Ing-Jun
    Tan, Mian-Shin
    PEDIATRIC PULMONOLOGY, 2011, 46 (01) : 45 - 59
12345